Fortress Biotech, Inc.
FBIOP$72M
Micro CapNASDAQBiotechnology🇺🇸North America101 employees
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
FBIOP News
Catalyst Timeline
1 upcoming, 1 past
PDUFANext
FDA PDUFA Date (priority review)
Apr 6, 2026Confirmed
AI-extracted from news: Fortress to sell priority review voucher for $205M
SourceDrug Pipeline
No drugs found in this phase.
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply